Validated imaging biomarkers as decision-making tools in clinical trials and routine practice
This article is a joint effort of the European Imaging Biomarkers ALLiance (EIBALL) and European Society of Radiology (ESR). It reviews the present evidence for the use of biomarkers in clinical settings at various stages of the disease pathway, critically evaluates current practice, and sets out recommendations for using imaging in patient management decision-making.
Article: Validated imaging biomarkers as decision-making tools in clinical trials and routine practice: current status and recommendations from the EIBALL* subcommittee of the European Society of Radiology (ESR)
Authors: Nandita M. deSouza, Eric Achten, Angel Alberich-Bayarri, Fabian Bamberg, Ronald Boellaard, Olivier Clément, Laure Fournier, Ferdia Gallagher, Xavier Golay, Claus Peter Heussel, Edward F. Jackson, Rashindra Manniesing, Marius E. Mayerhofer, Emanuele Neri, James O’Connor, Kader Karli Oguz, Anders Persson, Marion Smits, Edwin J. R. van Beek, Christoph J. Zech & European Society of Radiology